
Contraceptive Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Description
Growth Factors of Contraceptive Devices Market
The global contraceptive devices market has experienced significant growth over the past few decades, driven by increased awareness of contraception, effective methods for preventing conception, and robust government initiatives promoting women's and child health. According ta report by Fortune Business Insights, the market was valued at USD 7,013.8 million in 2017 and is projected treach USD 16,648.3 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period.
Market Segmentation
Contraceptive devices are broadly categorized based on product type, technology, and distribution channels.
Female Contraceptive Devices: This segment includes vaginal rings, intrauterine devices (IUDs), sub-dermal implants, female condoms, diaphragms, and sponges. The availability and variety of female contraceptive devices, along with the significant uptake of IUDs globally, are propelling sales in this segment. Female contraceptive devices are expected tremain dominant throughout the forecast period.
Barrier Contraceptives
Retail Pharmacy
Clinics
Online Channels
Public Channel & NGOs
Others
Regional Analysis
North America dominated the contraceptive devices market with a market share of 48.74% in 2017, accounting for USD 3,418.8 million. This dominance is attributable tthe upsurge in the usage of male condoms in the U.S. and Canada. However, the Asia Pacific region is anticipated texhibit the highest CAGR during the forecast period. Proactive governments in densely populated countries such as China and India are focusing on implementing population control measures, thereby augmenting the market in this region.
Key Market Drivers
1. Government Initiatives: Active participation by governments in promoting family planning and contraception, especially in emerging nations, is a key factor driving the global contraceptive devices market. Robust government promotions and schemes for women's and child health have significantly increased the use of contraceptive devices.
2. Awareness and Education: Improving literacy rates, especially among women, have encouraged the rapid adoption of contraceptive devices. Awareness of contraception and the presence of effective methods for preventing conception are major determinants of national pregnancy and birth rates.
3. Technological Advancements: The introduction of novel contraceptive devices, such as hormonal implants and advanced IUDs, has provided users with more options, thereby increasing adoption rates. For instance, in September 2016, Bayer AG received FDA approval for Kyleena, an intrauterine system for the intentional prevention of pregnancy for up tfive years, providing a new birth control option for women.
Challenges
Despite the positive growth trajectory, the contraceptive devices market faces certain challenges:
The contraceptive devices market is poised for substantial growth in the coming years. Factors such as increasing awareness, government initiatives, and technological advancements are expected tcontinue driving the market. Moreover, the focus on women's health and reproductive rights is likely tlead tmore supportive policies and funding, further propelling market growth.
In conclusion, the global contraceptive devices market is undergoing significant transformation, with a positive outlook for the future. Stakeholders, including manufacturers, healthcare providers, and governments, play crucial roles in addressing challenges and ensuring the availability and acceptance of contraceptive devices worldwide.
SEGMENTATION DETAILS
By Product Type
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
The global contraceptive devices market has experienced significant growth over the past few decades, driven by increased awareness of contraception, effective methods for preventing conception, and robust government initiatives promoting women's and child health. According ta report by Fortune Business Insights, the market was valued at USD 7,013.8 million in 2017 and is projected treach USD 16,648.3 million by 2032, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period.
Market Segmentation
Contraceptive devices are broadly categorized based on product type, technology, and distribution channels.
- Product Type:
Female Contraceptive Devices: This segment includes vaginal rings, intrauterine devices (IUDs), sub-dermal implants, female condoms, diaphragms, and sponges. The availability and variety of female contraceptive devices, along with the significant uptake of IUDs globally, are propelling sales in this segment. Female contraceptive devices are expected tremain dominant throughout the forecast period.
- Technology:
Barrier Contraceptives
- Distribution Channels:
Retail Pharmacy
Clinics
Online Channels
Public Channel & NGOs
Others
Regional Analysis
North America dominated the contraceptive devices market with a market share of 48.74% in 2017, accounting for USD 3,418.8 million. This dominance is attributable tthe upsurge in the usage of male condoms in the U.S. and Canada. However, the Asia Pacific region is anticipated texhibit the highest CAGR during the forecast period. Proactive governments in densely populated countries such as China and India are focusing on implementing population control measures, thereby augmenting the market in this region.
Key Market Drivers
1. Government Initiatives: Active participation by governments in promoting family planning and contraception, especially in emerging nations, is a key factor driving the global contraceptive devices market. Robust government promotions and schemes for women's and child health have significantly increased the use of contraceptive devices.
2. Awareness and Education: Improving literacy rates, especially among women, have encouraged the rapid adoption of contraceptive devices. Awareness of contraception and the presence of effective methods for preventing conception are major determinants of national pregnancy and birth rates.
3. Technological Advancements: The introduction of novel contraceptive devices, such as hormonal implants and advanced IUDs, has provided users with more options, thereby increasing adoption rates. For instance, in September 2016, Bayer AG received FDA approval for Kyleena, an intrauterine system for the intentional prevention of pregnancy for up tfive years, providing a new birth control option for women.
Challenges
Despite the positive growth trajectory, the contraceptive devices market faces certain challenges:
- Side Effects: Some contraceptive devices, particularly hormonal ones, may have side effects such as nausea, headaches, and mood changes, which can deter usage.
- Cultural and Religious Beliefs: In certain regions, cultural and religious beliefs may hinder the acceptance and use of contraceptive devices.
- Access and Availability: In low-income and rural areas, access ta variety of contraceptive devices may be limited due teconomic constraints or lack of healthcare infrastructure.
The contraceptive devices market is poised for substantial growth in the coming years. Factors such as increasing awareness, government initiatives, and technological advancements are expected tcontinue driving the market. Moreover, the focus on women's health and reproductive rights is likely tlead tmore supportive policies and funding, further propelling market growth.
In conclusion, the global contraceptive devices market is undergoing significant transformation, with a positive outlook for the future. Stakeholders, including manufacturers, healthcare providers, and governments, play crucial roles in addressing challenges and ensuring the availability and acceptance of contraceptive devices worldwide.
SEGMENTATION DETAILS
By Product Type
- Male Contraceptive Devices
- Female Contraceptive Devices
- Female Condoms, Diaphragms & Sponges
- Vaginal Rings
- Intrauterine Devices
- Sub-dermal Implants
- Others
- Hormonal Contraceptives
- Barrier Contraceptives
- Hospital Pharmacy
- Retail Pharmacy
- Clinics
- Online Channels
- Public Channel & NGO
- Others
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexicand Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
Table of Contents
148 Pages
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Fertility Statistics - Key Countries, 2017
- 4.2. New Product Launch
- 4.3. Key Industry Trends
- 4.4. Regulatory Scenario - Key Countries
- 4.5. Key Technological Advancements
- 4.6. Recent Industry Developments - Partnerships, Mergers & Acquisitions
- 5. Global Contraceptive Devices Market Analysis, Insights, and Forecast (2014-2025)
- 5.1. Key Findings/ Summary
- 5.2. Market Analysis, Insights, and Forecast – By Product Type
- 5.2.1. Male Contraceptive Devices
- 5.2.2. Female Contraceptive Devices
- 5.2.2.1. Female Condoms, Diaphragms & Sponges
- 5.2.2.2. Vaginal Rings
- 5.2.2.3. Intrauterine Devices
- 5.2.2.4. Sub-dermal Implants
- 5.2.2.5. Others
- 5.3. Market Analysis, Insights, and Forecast – By Technology
- 5.3.1. Hormonal Contraceptives
- 5.3.2. Barrier Contraceptives
- 5.4. Market Analysis, Insights, and Forecast – By Distribution Channel
- 5.4.1. Hospital Pharmacy
- 5.4.2. Retail Pharmacy
- 5.4.3. Clinics
- 5.4.4. Online Channel
- 5.4.5. Public Channel & NGOs
- 5.4.6. Others
- 5.5. Market Analysis, Insights, and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Contraceptive Devices Market Analysis, Insights, and Forecast (2014-2025)
- 6.1. Key Findings/ Summary
- 6.2. Market Analysis, Insights, and Forecast – By Product Type
- 6.2.1. Male Contraceptive Devices
- 6.2.2. Female Contraceptive Devices
- 6.2.2.1. Female Condoms, Diaphragms & Sponges
- 6.2.2.2. Vaginal Rings
- 6.2.2.3. Intrauterine Devices
- 6.2.2.4. Sub-dermal Implants
- 6.2.2.5. Others
- 6.3. Market Analysis, Insights, and Forecast – By Technology
- 6.3.1. Hormonal Contraceptives
- 6.3.2. Barrier Contraceptives
- 6.4. Market Analysis, Insights, and Forecast – By Distribution Channel
- 6.4.1. Hospital Pharmacy
- 6.4.2. Retail Pharmacy
- 6.4.3. Clinics
- 6.4.4. Online Channel
- 6.4.5. Public Channel & NGOs
- 6.4.6. Others
- 6.5. Market Analysis, Insights, and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Contraceptive Devices Market Analysis, Insights, and Forecast (2014-2025)
- 7.1. Key Findings/ Summary
- 7.2. Market Analysis, Insights, and Forecast – By Product Type
- 7.2.1. Male Contraceptive Devices
- 7.2.2. Female Contraceptive Devices
- 7.2.2.1. Female Condoms, Diaphragms & Sponges
- 7.2.2.2. Vaginal Rings
- 7.2.2.3. Intrauterine Devices
- 7.2.2.4. Sub-dermal Implants
- 7.2.2.5. Others
- 7.3. Market Analysis, Insights, and Forecast – By Technology
- 7.3.1. Hormonal Contraceptives
- 7.3.2. Barrier Contraceptives
- 7.4. Market Analysis, Insights, and Forecast – By Distribution Channel
- 7.4.1. Hospital Pharmacy
- 7.4.2. Retail Pharmacy
- 7.4.3. Clinics
- 7.4.4. Online Channel
- 7.4.5. Public Channel & NGOs
- 7.4.6. Others
- 7.5. Market Analysis, Insights, and Forecast – By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- (Similar structured sections for Asia Pacific, Latin America, and Middle East & Africa)
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2017)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials)
- 11.5.1. Bayer AG
- 11.5.2. Pfizer Inc.
- 11.5.3. Janssen Global Services, LLC
- 11.5.4. Teva Pharmaceutical Industries Ltd.
- 11.5.5. Merck & Co., Inc.
- 11.5.6. Mylan N.V.
- 11.5.7. Allergan
- 11.5.8. Reckitt Benckiser Group plc
- 11.5.9. Veru Inc.
- 11.5.10. Church & Dwight Co., Inc.
- 11.5.11. Medisafe Distribution Inc.
- 11.5.12. Other Prominent Players
- 12. Strategic Recommendations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.